Precise Neoadjuvant Chemoresection of Low Grade NMIBC

Clinical trial NCT06227065 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06227065
Sponsor: University of Bern
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Bladder Cancer Non-muscle Invasive Bladder Cancer Low-risk

Start date: 2024-10-01
Primary completion: 2026-10-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.